TY - JOUR
T1 - Mutations in USP9X are associated with x-linked intellectual disability and disrupt neuronal cell migration and growth
AU - Homan, Claire C.
AU - Kumar, Raman
AU - Nguyen, Lam Son
AU - Haan, Eric
AU - Raymond, F. Lucy
AU - Abidi, Fatima
AU - Raynaud, Martine
AU - Schwartz, Charles E.
AU - Wood, Stephen A.
AU - Gecz, Jozef
AU - Jolly, Lachlan A.
N1 - Funding Information:
We are grateful for the cooperation of the families involved in this study. We thank Vishva M. Dixit, Gentech, Genentech, Inc. (San Francisco, CA, USA) for the provision of the pRK5-USP9X plasmid; Orly Reiner, Weizmann Institute of Science (Rehovot, Israel) for providing the Flag-Dcx plasmid; and Steven Reed, The Scripps Research Institute (San Diego, CA, USA) for the 6xHA-Ubiquitin plasmid. This work was supported by the Women’s and Children’s Hospital Foundation Grant to L.A.J.; the National Health and Medical Research Council of Australia grants APP628952, APP1041920, and APP1008077 to J.G. and APP1009248 to S.A.W.; National Institutes of Health 2R01HD026202 (NICHD) and 1R01NS73854 (NINDS) to C.S.; and an Australian Postgraduate Award Scholarship to C.C.H.
PY - 2014/3/6
Y1 - 2014/3/6
N2 - With a wealth of disease-associated DNA variants being recently reported, the challenges of providing their functional characterization are mounting. Previously, as part of a large systematic resequencing of the X chromosome in 208 unrelated families with nonsyndromic X-linked intellectual disability, we identified three unique variants (two missense and one protein truncating) in USP9X. To assess the functional significance of these variants, we took advantage of the Usp9x knockout mouse we generated. Loss of Usp9x causes reduction in both axonal growth and neuronal cell migration. Although overexpression of wild-type human USP9X rescued these defects, all three USP9X variants failed to rescue axonal growth, caused reduced USP9X protein localization in axonal growth cones, and (in 2/3 variants) failed to rescue neuronal cell migration. Interestingly, in one of these families, the proband was subsequently identified to have a microdeletion encompassing ARID1B, a known ID gene. Given our findings it is plausible that loss of function of both genes contributes to the individual's phenotype. This case highlights the complexity of the interpretations of genetic findings from genome-wide investigations. We also performed proteomics analysis of neurons from both the wild-type and Usp9x knockout embryos and identified disruption of the cytoskeleton as the main underlying consequence of the loss of Usp9x. Detailed clinical assessment of all three families with USP9X variants identified hypotonia and behavioral and morphological defects as common features in addition to ID. Together our data support involvement of all three USP9X variants in ID in these families and provide likely cellular and molecular mechanisms involved.
AB - With a wealth of disease-associated DNA variants being recently reported, the challenges of providing their functional characterization are mounting. Previously, as part of a large systematic resequencing of the X chromosome in 208 unrelated families with nonsyndromic X-linked intellectual disability, we identified three unique variants (two missense and one protein truncating) in USP9X. To assess the functional significance of these variants, we took advantage of the Usp9x knockout mouse we generated. Loss of Usp9x causes reduction in both axonal growth and neuronal cell migration. Although overexpression of wild-type human USP9X rescued these defects, all three USP9X variants failed to rescue axonal growth, caused reduced USP9X protein localization in axonal growth cones, and (in 2/3 variants) failed to rescue neuronal cell migration. Interestingly, in one of these families, the proband was subsequently identified to have a microdeletion encompassing ARID1B, a known ID gene. Given our findings it is plausible that loss of function of both genes contributes to the individual's phenotype. This case highlights the complexity of the interpretations of genetic findings from genome-wide investigations. We also performed proteomics analysis of neurons from both the wild-type and Usp9x knockout embryos and identified disruption of the cytoskeleton as the main underlying consequence of the loss of Usp9x. Detailed clinical assessment of all three families with USP9X variants identified hypotonia and behavioral and morphological defects as common features in addition to ID. Together our data support involvement of all three USP9X variants in ID in these families and provide likely cellular and molecular mechanisms involved.
UR - http://www.scopus.com/inward/record.url?scp=84896768982&partnerID=8YFLogxK
U2 - 10.1016/j.ajhg.2014.02.004
DO - 10.1016/j.ajhg.2014.02.004
M3 - Article
C2 - 24607389
AN - SCOPUS:84896768982
SN - 0002-9297
VL - 94
SP - 470
EP - 478
JO - American Journal of Human Genetics
JF - American Journal of Human Genetics
IS - 3
ER -